TY - JOUR
T1 - The gene encoding ATP-binding cassette transporter I is mutated in Tangier disease
AU - Bodzioch, Marek
AU - Orsó, Evelyn
AU - Klucken, Jochen
AU - Langmann, Thomas
AU - Böttcher, Alfred
AU - Diederich, Wendy
AU - Drobnik, Wolfgang
AU - Barlage, Stefan
AU - Büchler, Christa
AU - Porsch-Özcürümez, Mustafa
AU - Kaminski, Wolfgang E.
AU - Hahmann, Harry W.
AU - Oette, Kurt
AU - Rothe, Gregor
AU - Aslanidis, Charalampos
AU - Lackner, Karl J.
AU - Schmitz, Gerd
PY - 1999/8
Y1 - 1999/8
N2 - Tangier disease (TD) is an autosomal recessive disorder of lipid metabolism. It is characterized by absence of plasma high-density lipoprotein (HDL) and deposition of cholesteryl esters in the reticulo-endothelial system with splenomegaly and enlargement of tonsils and lymph nodes. Although low HDL cholesterol is associated with an increased risk for coronary artery disease, this condition is not consistently found in TD pedigrees. Metabolic studies in TD patients have revealed a rapid catabolism of HDL and its precursors. In contrast to normal mononuclear phagocytes (MNP), MNP from TD individuals degrade internalized HDL in unusual lysosomes, indicating a defect in cellular lipid metabolism. HDL-mediated cholesterol efflux and intracellular lipid trafficking and turnover are abnormal in TD fibroblasts, which have a reduced in vitro growth rate. The TD locus has been mapped to chromosome 9q31 (ref. 9). Here we present evidence that TD is caused by mutations in ABC1, encoding a member of the ATP-binding cassette (ABC) transporter family, located on chromosome 9q22-31 (ref. 10). We have analysed five kindreds with TD and identified seven different mutations, including three that are expected to impair the function of the gene product. The identification of ABC1 as the TD locus has implications for the understanding of cellular HDL metabolism and reverse cholesterol transport, and its association with premature cardiovascular disease.
AB - Tangier disease (TD) is an autosomal recessive disorder of lipid metabolism. It is characterized by absence of plasma high-density lipoprotein (HDL) and deposition of cholesteryl esters in the reticulo-endothelial system with splenomegaly and enlargement of tonsils and lymph nodes. Although low HDL cholesterol is associated with an increased risk for coronary artery disease, this condition is not consistently found in TD pedigrees. Metabolic studies in TD patients have revealed a rapid catabolism of HDL and its precursors. In contrast to normal mononuclear phagocytes (MNP), MNP from TD individuals degrade internalized HDL in unusual lysosomes, indicating a defect in cellular lipid metabolism. HDL-mediated cholesterol efflux and intracellular lipid trafficking and turnover are abnormal in TD fibroblasts, which have a reduced in vitro growth rate. The TD locus has been mapped to chromosome 9q31 (ref. 9). Here we present evidence that TD is caused by mutations in ABC1, encoding a member of the ATP-binding cassette (ABC) transporter family, located on chromosome 9q22-31 (ref. 10). We have analysed five kindreds with TD and identified seven different mutations, including three that are expected to impair the function of the gene product. The identification of ABC1 as the TD locus has implications for the understanding of cellular HDL metabolism and reverse cholesterol transport, and its association with premature cardiovascular disease.
UR - http://www.scopus.com/inward/record.url?scp=0032813809&partnerID=8YFLogxK
U2 - 10.1038/11914
DO - 10.1038/11914
M3 - Article
C2 - 10431237
AN - SCOPUS:0032813809
SN - 1061-4036
VL - 22
SP - 347
EP - 351
JO - Nature Genetics
JF - Nature Genetics
IS - 4
ER -